Selective Serotonin Reuptake Inhibitor and Serotonin-Noradrenaline Reuptake Inhibitor Withdrawal Changes DSM Presentation of Mental Disorders: Results from the Diagnostic Clinical Interview for Drug Withdrawal
Psychotherapy and Psychosomatics · 2024
DOI: 10.1159/000540031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychotherapy and Psychosomatics, 2024. Verfasst von Fiammetta Cosci und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, University of Florence, Florence, Italy. Hauptthemen laut MEDLINE: Substance Withdrawal Syndrome, Selective Serotonin Reuptake Inhibitors, Diagnostic and Statistical Manual of Mental Disorders, Serotonin and Noradrenaline Reuptake Inhibitors. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 14 Literaturangaben.
Abstract (Originalsprache)
Introduction
Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) may cause withdrawal at dose decrease, discontinuation, or switch. Current diagnostic methods (e.g., DSM) do not take such phenomenon into account. Using a new nosographic classification of withdrawal syndromes due to SSRI/SNRI decrease or discontinuation [by Psychother Psychosom. 2015;84(2):63–71], we explored whether DSM is adequate to identify DSM disorders when withdrawal occurs.
Methods
Seventy-five self-referred patients with a diagnosis of withdrawal syndrome due to discontinuation of SSRI/SNRI, diagnosed via the Diagnostic Clinical Interview for Drug Withdrawal 1 – New Symptoms of Selective Serotonin Reuptake Inhibitors or Serotonin-Norepinephrine Reuptake Inhibitors (DID-W1), and at least one DSM-5 diagnosis were analyzed.
Results
In 58 cases (77.3%), the DSM-5 diagnosis of current mental disorder was not confirmed when the DID-W1 diagnosis of current withdrawal syndrome was established. In 13 cases (17.3%), the DSM-5 diagnosis of past mental disorder was not confirmed when criteria for DID-W1 diagnosis of lifetime withdrawal syndrome were met. In 3 patients (4%), the DSM-5 diagnoses of current and past mental disorders were not confirmed when the DID-W1 diagnoses of current and lifetime withdrawal syndromes were taken into account. The DSM-5 diagnoses most frequently mis-formulated were current panic disorder (50.7%, n = 38) and past major depressive episode (18.7%, n = 14).
Conclusion
DSM needs to be complemented by clinimetric tools, such as the DID-W1, to detect withdrawal syndromes induced by SSRI/SNRI discontinuation, decrease, or switch, following long-term use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Sciences, University of Florence, Florence, Italy.
- International Lab of Clinical Measurements, University of Florence, Florence, Italy.
- Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, The Netherlands.
- Psychotic Disorders Division, McLean Hospital, Harvard Medical School, Belmont, Massachusetts, USA.
- University Mental Health Institute of Montreal, University of Montreal, Montreal, Québec, Canada.
- Clinical Pharmacology and Toxicology Program, Royal College of Physicians and Surgeons, McGill University, Montreal, Québec, Canada.
Zitieren
APA
Cosci, F., Chouinard, V. A., & Chouinard, G. (2024). Selective Serotonin Reuptake Inhibitor and Serotonin-Noradrenaline Reuptake Inhibitor Withdrawal Changes DSM Presentation of Mental Disorders: Results from the Diagnostic Clinical Interview for Drug Withdrawal. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000540031
Vancouver
Cosci F, Chouinard VA, Chouinard G. Selective Serotonin Reuptake Inhibitor and Serotonin-Noradrenaline Reuptake Inhibitor Withdrawal Changes DSM Presentation of Mental Disorders: Results from the Diagnostic Clinical Interview for Drug Withdrawal. Psychotherapy and Psychosomatics. 2024. doi:10.1159/000540031
BibTeX
@article{Cosci2024,
author = {Cosci, Fiammetta and Chouinard, Virginie-Anne and Chouinard, Guy},
title = {Selective Serotonin Reuptake Inhibitor and Serotonin-Noradrenaline Reuptake Inhibitor Withdrawal Changes DSM Presentation of Mental Disorders: Results from the Diagnostic Clinical Interview for Drug Withdrawal},
journal = {Psychotherapy and Psychosomatics},
year = {2024},
doi = {10.1159/000540031}
}
EUVIMED